Skip to main content

Rosetta Green Licenses microRNA from Iowa State

Premium

Rosetta Green said this week that it has signed an agreement under which it licensed an undisclosed microRNA from Iowa State University for use in developing plants resistant to nematodes.

Specific terms of the deal were not disclosed.

“Nematode worms are an increasing worldwide problem due to the lack of measures against this pest,” Rosetta Green CEO Amir Avniel said in a statement. “We see once again the potential of microRNA genes to improve plant traits.”

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.